Profile data is unavailable for this security.
About the company
PharmaCorp Rx Inc. is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. The Company operates approximately seven PharmaChoice Canada bannered pharmacies in Canada and continues to acquire PharmaChoice Canada branded pharmacies as they come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The Company also acquires independently owned non-PharmaChoice Canada bannered pharmacies in Canada, and thereafter, continues to operate such acquired pharmacies under a PharmaChoice Canada banner.
- Revenue in CAD (TTM)17.60m
- Net income in CAD189.64k
- Incorporated2021
- Employees--
- LocationPharmaCorp Rx IncSuite #203, 303 Wellman LaneSASKATOON S7T0J1CanadaCAN
- Phone+1 (306) 536-3771
- Websitehttps://www.pharmacorprx.ca/
More ▼
Mergers & acquisitions
| Acquired company | PCRX:CVE since announced | Transaction value |
|---|---|---|
| Undisclosed Pharmacy Business | -3.26% | 1.75m |
Data delayed at least 15 minutes, as of Feb 13 2026 20:59 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tokyo Lifestyle Co Ltd (ADR) | 412.00m | 6.05m | 17.41m | 130.00 | -- | 0.3024 | 2.31 | 0.0423 | -1.43 | -1.43 | 69.38 | 9.99 | 1.70 | 43.25 | 2.36 | 2,327,209.00 | 2.47 | 2.28 | 8.21 | 6.23 | 9.10 | 15.82 | 1.45 | 1.44 | 1.20 | 3.54 | 0.6262 | -- | 7.38 | 8.53 | -11.24 | 6.30 | -21.90 | -- |
| Ridgetech Inc | 163.38m | -1.99m | 35.36m | 61.00 | -- | 0.2805 | -- | 0.2164 | -0.2802 | 1.76 | 21.64 | 5.06 | 1.50 | 8.93 | 5.50 | 1,966,748.00 | -1.82 | -6.17 | -5.57 | -18.43 | 3.20 | 11.80 | -1.21 | -4.48 | 1.45 | -- | 0.2595 | -- | -3.24 | 0.4467 | -85.77 | -- | -23.07 | -- |
| PharmaCorp Rx Inc | 17.60m | 189.64k | 77.47m | -- | 300.68 | 1.74 | 77.19 | 4.40 | 0.0015 | 0.0015 | 0.1475 | 0.2556 | 0.4904 | 7.59 | 34.91 | -- | 0.5088 | -- | 0.5426 | -- | 39.77 | -- | 1.04 | -- | 1.79 | -- | 0.1251 | -- | -- | -- | -115.30 | -- | -- | -- |
| CareRx Corp | 366.34m | 93.00k | 242.36m | 1.42k | 13,310.34 | 2.79 | 12.98 | 0.6616 | -0.0009 | -0.0009 | 5.72 | 1.39 | 1.65 | 14.00 | 11.80 | 257,442.70 | 0.042 | -7.81 | 0.0582 | -10.61 | 29.81 | 28.82 | 0.0254 | -5.52 | 0.828 | 1.29 | 0.4844 | -- | -1.09 | 24.09 | 16.73 | -- | 18.32 | -- |
Data as of Feb 13 2026. Currency figures normalised to PharmaCorp Rx Inc's reporting currency: Canadian Dollar CAD
7.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Claret Asset Management Corp.as of 31 Dec 2025 | 12.94m | 7.48% |
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
